Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma

Pathobiology

Volumn 69, Issue 6, 2001, Pages 297-303

  Nemoto, Tsuyoshi ^a   Terashima, Shinya ^a   Kogure, Michihiko ^a   Hoshino, Yutaka ^a   Kusakabe, Takashi ^a   Suzuki, Toshimitsu ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Fatty acid synthase; Immunohistochemistry; Oesophageal squamous cell cancer; Oesophageal squamous cell dysplasia

Indexed keywords

FATTY ACID SYNTHASE;

ADULT; AGED; ARTICLE; BASAL CELL; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL COUNT; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; SURVIVAL RATE;

EID: 0035789570     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064636     Document Type: Article

References (40)

1. Pisani P, Parkin M, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E: Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-590.
3. Siewert JR, Bartels H, Bollschweiler E, Dittler HJ, Fink U, Heolscher AH, Roder JD: Platten-epithelcarcinom des Oesophagus: Behandlungskonzept der Chirurgischen Klinik der Technischen Universität München. Chirurg 1992;63:693-700.
4. Watanabe H: Plattenepithelcarcinom des Oesophagus. Chirurg 1992;63:689-692.
5. Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B: Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial. Br J Surg 1993;80:367-370.
6. Wakil SJ: Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 1989;28:4523-3430.
7. Volpe JJ, Vagelos PR: Mechanisms and regulation of biosynthesis of saturated fatty acids. Physiol Rev 1976;56:339-417.
8. McCarthy AD, Hardie DG: Fatty acid synthase: An example of protein evolution by gene fusion. Trends Biochem Sci 1984;9:60-63.
9. Paulauskis JD, Sul HS: Hormonal reguration of mouse fatty acid synthase gene transcription in liver. J Biol Chem 1989;264:574-577.
10. Goldrick RB, Galton DJ: Fatty acid synthesis de novo in human adipose tissue. Clin Sci Mol Med 1974;46:469-479.
11. Escot C, Joyeux C, Mathieu M, Maudelonde T, Pages A, Rochefort H, Chalbos D: Regulation of fatty acid synthetase ribonucleic acid in the human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1990;70:1319-1324.
12. Pope TS, Smart DA, Rooney SA: Hormonal effect on fatty-acid synthase in cultured fetal rat lung; induction by dexamethasone and inhibition of activity by triiodothyronine. Biochem Biophys Acta 1988;959:169-177.
13. Smith S, Ryan P: Asynchronous appearance of two enzymes concerned with medium chain fatty acid synthesis in developing rat mammary gland. J Biol Chem 1979;254:8921-8936.
14. Joyeux C, Chalbos D, Rochefort H: Effects of progestins and menstrual cycle on fatty acid synthase and progesterone receptor in human mammary glands. J Clin Endocrinol Metab 1990;70:9923-9926.
15. Chalbos D, Chambon M, Ailhaud G, Rochefort H: Fatty acid synthase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem 1987;262:9923-9926.
16. Kuhajda FP, Piantadosi S, Pasternack GR: Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med 1989;321:636-641.
17. Chalbos D, Escot C, Joyeux C, Tissot-Carayon M-J, Pages A, Rochefort H: Expression of the progestin-induced fatty acid synthase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J Natl Cancer Inst 1990;82:602-606.
18. Chalbos D, Joyeux C, Galtier F, Rochefort H: Progestin-induced fatty acid synthase in breast cancer. Ann NY Acad Sci 1990;595:67-73.
19. Chalbos D, Joyeux C, Galtier F, Rochefort H: Progestin-induced fatty acid synthase in human mammary tumors: From molecular to clinical studies. J Steroid Biochem Mol Biol 1992;43:223-228.
20. Pizer ES, Wood FD, Pasternack GR, Kuhajda FP: Altered fatty acid biosynthesis in endometrial carcinoma. Mod Pathol 1995;8:95A.
21. Gansler TS, Hardman W, Hunt DA, Schaffel S, Hennigar RA: Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997;28:686-692.
22. Epstein JI, Carmichael MJ, Partin AW: OA-519 (fatty acid synthase) as an independent predictor of pathological stage in adenocarcinoma of the prostata. Urology 1995;45:81-86.
23. Corrigan C, Martin AW, Lear SC, Lear SC, Kuhns G, Kuhajda FP, Pasternack GR: Prognostic value of the immunohistochemical demonstration of haptoglobin-related protein in breast cancer. Am J Clin Pathol 1991;96:406.
24. Jensen V, Ladekael M, Holm-Nielsen P, Flemming BS, Flemming M: The prognostic value of oncogenic antigen (OA-519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J Pathol 1995;176:343-352.
25. Alo PL, Visca P, Trombetta G, Mangoni A, Lenti L, Monaco S, Botti C, Serpieri E, Di Tondo U: Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999;85:35-40.
26. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U: Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 1996;77:474-482.
27. Nakamura I, Kimijima I, Zhang G, Onogi H, Endo Y, Suzuki S, Tsuchiya A, Takenoshita S, Kusakabe T, Suzuki T: Fatty acid synthase expression in Japanese breast carcinoma patients. Int J Mol Med 1999;4:381-387.
28. Shurbaji MS, Kuhajda FP, Pasternack GR, Thurmond TS: Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. Am J Clin Pathol 1992;97:686-691.
29. Shurbaji MS, Kalbfleisch JH, Thurmond TS: Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 1996;27:917-921.
30. Carmichael MJ, Epstein JI, Partin AW: OA-519 (fatty acid synthase) a novel prognostic marker for prostate cancer: Correlation with pathologic stage. Mod Pathol 1995;7:7A.
31. Rashid A, Pizer ES, Moga, et al: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-208.
32. Kusakabe T, Nashimoto A, Honma K, Suzuki T: Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 2002;40:71-79.
33. Krontiras H, Roye GD, Beenken SE, Myers RB, Mayo MS, Peters GE, Grizzle WE: Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck 1999;21:325-329.
34. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimberger DG, Grizzle WE: The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000;31:1068-1073.
35. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Fukuda T, Suzuki T: Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 2000;48:613-622.
36. Koga Y, Kuwano H, Sugimachi K: Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer 1996;77:237-244.
37. Sobin LH, Wittekind (eds): International Union against Cancer: TNM Classification of Malignant Tumours, ed 5. New York, Wiley-Liss, 1997.
38. Pizer ES, Wood FD, Pastermack GR, Kuhajda FP: Fatty acid synthase (FAS): A target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res 1996;56:745-751.
39. Pizer ES, Chrest FJ, Digiuseppe JA, Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DVA replication and induce apoptosis in tumor cell lines. Cancer Res 1998;58:4611-4615.
40. Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS: A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: A critical analysis. J Urol 1989;142:1254-1258.